Sign in to view content

Subretinal Delivery of Investigational ABBV-RGX-314 for Neovascular Age-Related Macular Degeneration: A Phase II Pharmacodynamic Study

Edward H. Wood, MD, FASRS

Video
Published 2024

Related

Phase 2 Population Extension Cohort in the PRISM Trial Evaluating 4D-150 in Adults With Neovascular Age-related Macular Degeneration
Raj K. Maturi, MD
Annual Meeting Talks
2024
Intravitreal Gene Therapy for Neovascular AMD with ADVM-022: Results of the Phase 1 OPTIC Trial
Dante Joseph Pieramici, MD
Annual Meeting Talks
2021
Creating Blebs for Subretinal Gene Delivery
Andreas K. Lauer, MD
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more